Manufacturer
Eli Lilly
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 117
- Molecules
- 28
- Therapy areas
- 10
Eli Lilly is a pharmaceutical manufacturer based in United States. MedsAcross lists 117 of its products across 28 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Eli Lilly Co. Ltd., Eli Lilly and Company, Eli Lilly and Company Limited
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Eli Lilly products through licensed channels, with the documents your regulator needs.
Diabetes
67 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| BASAGLAR KwikPen 100 IU/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
| Foundayo 0.8 mg tabletOral | Orforglipron | US FDA | Available on request |
| Foundayo 14.5 mg tabletOral | Orforglipron | US FDA | Available on request |
| Foundayo 17.2 mg tabletOral | Orforglipron | US FDA | Available on request |
| Foundayo 2.5 mg tabletOral | Orforglipron | US FDA | Available on request |
| Foundayo 5.5 mg tabletOral | Orforglipron | US FDA | Available on request |
| Foundayo 9 mg tabletOral | Orforglipron | US FDA | Available on request |
| Humalog 100 IU/mL injectionIntravenous, subcutaneous | Insulin lispro | US FDA | Available on request |
| Humalog Junior KwikPen 100 IU/mL injectionSubcutaneous | Insulin lispro | US FDA | Available on request |
| Humalog KwikPen 100 IU/mL injectionIntravenous, subcutaneous | Insulin lispro | US FDA | Available on request |
| Humalog KwikPen 200 IU/mL injectionSubcutaneous | Insulin lispro | US FDA | Available on request |
| Humalog Mix50/50 KwikPen 100 IU/mL injectable suspensionSubcutaneous | Insulin lispro | US FDA | Available on request |
| Humalog Mix75/25 100 IU/mL injectable suspensionSubcutaneous | Insulin lispro | US FDA | Available on request |
| Humalog Mix75/25 KwikPen 100 IU/mL injectable suspensionSubcutaneous | Insulin lispro | US FDA | Available on request |
| Humalog Tempo Pen 100 IU/mL injectionSubcutaneous | Insulin lispro | US FDA | Available on request |
| Humulin R U-500 KwikPen 500 IU/mL injectionSubcutaneous | Insulin human | US FDA | Available on request |
| Insulin lispro 100 IU/mL injectionIntravenous, subcutaneousGeneric name | Insulin lispro | US FDA | Available on request |
| Insulin Lispro Junior KwikPen 100 IU/mL injectionSubcutaneous | Insulin lispro | US FDA | Available on request |
| Insulin Lispro KwikPen 100 IU/mL injectionIntravenous, subcutaneous | Insulin lispro | US FDA | Available on request |
| Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen 100 IU/mL injectable suspensionSubcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| Lyumjev 100 IU/mL injectionSubcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| Lyumjev 100 IU/mL injectionIntravenous, subcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| LYUMJEV Junior KwikPen 100 IU/mL injectionSubcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| LYUMJEV KwikPen 100 IU/mL injectionSubcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| LYUMJEV KwikPen 200 IU/mL injectionSubcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| LYUMJEV Tempo Pen 100 IU/mL injectionSubcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| Mounjaro 10 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 10.008 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 12.5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 15 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 19.992 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 2.5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 30 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 40.08 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 49.92 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 60 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro 7.5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro KwikPen 10.008 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro KwikPen 19.992 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro KwikPen 30 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro KwikPen 40.08 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro KwikPen 49.92 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Mounjaro KwikPen 60 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Rezvoglar KwikPen 100 IU/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
| Trulicity 0.75 mg/0.5 mL injectionSubcutaneous Cold chain | Dulaglutide | US FDA | Available on request |
| Trulicity 1.5 mg/0.5 mL injectionSubcutaneous Cold chain | Dulaglutide | US FDA | Available on request |
| Trulicity 3 mg/0.5 mL injectionSubcutaneous Cold chain | Dulaglutide | US FDA | Available on request |
| Trulicity 4.5 mg/0.5 mL injectionSubcutaneous Cold chain | Dulaglutide | US FDA | Available on request |
| Zepbound 10 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 10.008 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 12.5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 15 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 19.992 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 2.5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 30 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 40.08 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 49.92 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 60 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound 7.5 mg/0.5 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound KwikPen 10.008 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound KwikPen 19.992 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound KwikPen 30 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound KwikPen 40.08 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound KwikPen 49.92 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
| Zepbound KwikPen 60 mg/2.4 mL injectionSubcutaneous Cold chain | Tirzepatide | US FDA | Available on request |
Oncology
16 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Alimta 100 mg/4 mL powder for injectionIntravenous | Pemetrexed | US FDA | Available on request |
| Cyramza 100 mg/10 mL injectionIntravenous Cold chain | Ramucirumab | US FDA | Available on request |
| Cyramza 500 mg/50 mL injectionIntravenous Cold chain | Ramucirumab | US FDA | Available on request |
| Inluriyo 200 mg tabletOral | Imlunestrant | US FDA | Available on request |
| Jaypirca 100 mg tabletOral | Pirtobrutinib | US FDA | Available on request |
| Jaypirca 50 mg tabletOral | Pirtobrutinib | US FDA | Available on request |
| Retevmo 120 mg tabletOral | Selpercatinib | US FDA | Available on request |
| Retevmo 160 mg tabletOral | Selpercatinib | US FDA | Available on request |
| Retevmo 40 mg tabletOral | Selpercatinib | US FDA | Available on request |
| Retevmo 40 mg capsuleOral | Selpercatinib | US FDA | Available on request |
| Retevmo 80 mg tabletOral | Selpercatinib | US FDA | Available on request |
| Retevmo 80 mg capsuleOral | Selpercatinib | US FDA | Available on request |
| Verzenio 100 mg tabletOral | Abemaciclib | US FDA | Available on request |
| Verzenio 150 mg tabletOral | Abemaciclib | US FDA | Available on request |
| Verzenio 200 mg tabletOral | Abemaciclib | US FDA | Available on request |
| Verzenio 50 mg tabletOral | Abemaciclib | US FDA | Available on request |
Immunology and transplant
10 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Olumiant 1 mg tabletOral | Baricitinib | US FDA | Available on request |
| Olumiant 2 mg tabletOral | Baricitinib | US FDA | Available on request |
| Olumiant 4 mg tabletOral | Baricitinib | US FDA | Available on request |
| Omvoh kitSubcutaneous Cold chain | Mirikizumab | US FDA | Available on request |
| Omvoh 100 mg/1 mL injectionSubcutaneous Cold chain | Mirikizumab | US FDA | Available on request |
| Omvoh 200 mg/2 mL injectionSubcutaneous Cold chain | Mirikizumab | US FDA | Available on request |
| Omvoh 300 mg/15 mL injectionIntravenous Cold chain | Mirikizumab | US FDA | Available on request |
| Taltz 20 mg/0.25 mL injectionSubcutaneous Cold chain | Ixekizumab | US FDA | Available on request |
| Taltz 40 mg/0.5 mL injectionSubcutaneous Cold chain | Ixekizumab | US FDA | Available on request |
| Taltz 80 mg/1 mL injectionSubcutaneous Cold chain | Ixekizumab | US FDA | Available on request |
Psychiatry
8 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Kisunla 350 mg/20 mL injectionIntravenous Cold chain | Donanemab | US FDA | Available on request |
| Strattera 10 mg capsuleOral | Atomoxetine | US FDA | Available on request |
| Strattera 100 mg capsuleOral | Atomoxetine | US FDA | Available on request |
| Strattera 18 mg capsuleOral | Atomoxetine | US FDA | Available on request |
| Strattera 25 mg capsuleOral | Atomoxetine | US FDA | Available on request |
| Strattera 40 mg capsuleOral | Atomoxetine | US FDA | Available on request |
| Strattera 60 mg capsuleOral | Atomoxetine | US FDA | Available on request |
| Strattera 80 mg capsuleOral | Atomoxetine | US FDA | Available on request |
Pain and anaesthesia
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Emgality 100 mg/1 mL injectionSubcutaneous Cold chain | Galcanezumab | US FDA | Available on request |
| Emgality 120 mg/1 mL injectionSubcutaneous Cold chain | Galcanezumab | US FDA | Available on request |
| Reyvow 100 mg tabletOral | Lasmiditan | US FDA | Available on request |
| Reyvow 50 mg tabletOral | Lasmiditan | US FDA | Available on request |
Nephrology and urology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cialis 10 mg tabletOral | Tadalafil | US FDA | Available on request |
| Cialis 20 mg tabletOral | Tadalafil | US FDA | Available on request |
| Cialis 5 mg tabletOral | Tadalafil | US FDA | Available on request |
Endocrinology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Forteo 560 mcg/2.24 mL injectionSubcutaneous Cold chain | Teriparatide | US FDA | Available on request |
| Humatrope kitIntramuscular, subcutaneous | Somatropin | US FDA | Available on request |
Contrast media and diagnostics
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Amyvid 51 mCi/mL injectionIntravenous | Florbetapir f-18 | US FDA | Available on request |
Dermatology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Ebglyss 250 mg/2 mL injectionSubcutaneous Cold chain | Lebrikizumab | US FDA | Available on request |
Fertility
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Evista 60 mg tabletOral | Raloxifene | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| ONSWIK KwikPen 1000 IU/mL injectionSubcutaneous Cold chain | Insulin efsitora alfa | US FDA | Available on request |
| ONSWIK KwikPen 500 IU/mL injectionSubcutaneous Cold chain | Insulin efsitora alfa | US FDA | Available on request |
| Tauvid 100 mCi/mL injectionIntravenous | Flortaucipir f-18 | US FDA | Available on request |
| Water 1 mL/mL injectionSubcutaneousGeneric name | Water | US FDA | Available on request |
Molecules made
PemetrexedFlorbetapir f-18Insulin glargineTadalafilRamucirumabLebrikizumabGalcanezumabRaloxifeneTeriparatideOrforglipronInsulin lisproSomatropinInsulin humanImlunestrantPirtobrutinibDonanemabTirzepatideBaricitinibMirikizumabInsulin efsitora alfaSelpercatinibLasmiditanAtomoxetineIxekizumabFlortaucipir f-18DulaglutideAbemaciclibWater
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Eli Lilly
Send a request for any of these products. We confirm the licensed source, documents and lead time.